INMODE LTD
INMDNASDAQTrading Snapshot
- Day Range
- $13.31 β $13.62
- 52-Week Range
- $12.72 β $16.67
- Volume (shares)
- 536,105
- Avg Volume (shares)
- β
- Shares Outstanding
- 57.5M
- Next Earnings
- 2026-11-11
Fundamentals Snapshot
- Annual Revenue
- $370M
- Last Q Revenue
- $96M
- P/E Ratio
- 9.9
- P/S Ratio
- 2.0x
- EPS (TTM)
- $1.23
- Dividend Yield
- β
- Dilution (1yr)
- β12.0%
INMODE LTD
INMDAbout INMODE LTD
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, βSteelβ), a significant, long-standing shareholder of InMode Ltd. (βInModeβ or the βCompanyβ) (Nasdaq: INMD), today issued an open le

InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq:Β INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quar

Contrasting PAVmed (NASDAQ:PAVM) and InMode (NASDAQ:INMD)
PAVmed (NASDAQ: PAVM - Get Free Report) and InMode (NASDAQ: INMD - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength o

InMode: Hope Is Not An Effective Investment Strategy, But Neither Is Despair
InMode remains rangebound as US platform sales decline, but international growth and recurring consumables revenue provide stabilization. I maintain a 'buy' rating, downgraded from 'strong buy,' citing cyclical industry

Reviewing InMode (NASDAQ:INMD) & LogicMark (OTCMKTS:LGMKD)
LogicMark (OTCMKTS:LGMKD - Get Free Report) and InMode (NASDAQ: INMD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of t

Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)
InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strengt